Drugs Made In America Acquisition Corp. (DMAA)

DMAA Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024
Period Ending	Dec 31, 2024
Selling, General & Admin	0.48
Operating Expenses	0.48
Operating Income	-0.48
Pretax Income	-0.48
Net Income	-0.48
Net Income to Common	-0.48
Shares Outstanding (Basic)	9
Shares Outstanding (Diluted)	9
EPS (Basic)	-0.06
EPS (Diluted)	-0.06
EBIT	-0.48

Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q